EZH2: a novel target for cancer treatment
R Duan, W Du, W Guo - Journal of hematology & oncology, 2020 - Springer
Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of …
The long and short non-coding RNAs modulating EZH2 signaling in cancer
Non-coding RNAs (ncRNAs) are a large family of RNA molecules with no capability in
encoding proteins. However, they participate in developmental and biological processes …
encoding proteins. However, they participate in developmental and biological processes …
Context-specific Polycomb mechanisms in development
Polycomb group (PcG) proteins are crucial chromatin regulators that maintain repression of
lineage-inappropriate genes and are therefore required for stable cell fate. Recent advances …
lineage-inappropriate genes and are therefore required for stable cell fate. Recent advances …
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Multiple, complex molecular events characterize cancer development and progression,.
Deciphering the molecular networks that distinguish organ-confined disease from metastatic …
Deciphering the molecular networks that distinguish organ-confined disease from metastatic …
The polycomb group protein EZH2 is involved in progression of prostate cancer
Prostate cancer is a leading cause of cancer-related death in males and is second only to
lung cancer. Although effective surgical and radiation treatments exist for clinically localized …
lung cancer. Although effective surgical and radiation treatments exist for clinically localized …
Regulation of chromatin structure by site-specific histone H3 methyltransferases
The organization of chromatin into higher-order structures influences chromosome function
and epigenetic gene regulation. Higher-order chromatin has been proposed to be nucleated …
and epigenetic gene regulation. Higher-order chromatin has been proposed to be nucleated …
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
The Polycomb Group Protein EZH2 is a transcriptional repressor involved in controlling
cellular memory and has been linked to aggressive prostate cancer. Here we investigate the …
cellular memory and has been linked to aggressive prostate cancer. Here we investigate the …
Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein
A Kuzmichev, K Nishioka… - Genes & …, 2002 - genesdev.cshlp.org
Enhancer of Zeste [E (z)] is a Polycomb-group transcriptional repressor and one of the
founding members of the family of SET domain-containing proteins. Several SET-domain …
founding members of the family of SET domain-containing proteins. Several SET-domain …
[HTML][HTML] Histone methyltransferase activity of a Drosophila Polycomb group repressor complex
Polycomb group (PcG) proteins maintain transcriptional repression during development,
likely by creating repressive chromatin states. The Extra Sex Combs (ESC) and Enhancer of …
likely by creating repressive chromatin states. The Extra Sex Combs (ESC) and Enhancer of …
Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites
B Czermin, R Melfi, D McCabe, V Seitz, A Imhof… - Cell, 2002 - cell.com
Enhancer of Zeste is a Polycomb Group protein essential for the establishment and
maintenance of repression of homeotic and other genes. In the early embryo it is found in a …
maintenance of repression of homeotic and other genes. In the early embryo it is found in a …